Susquehanna International Group’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Susquehanna International Group’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,229	Closed	-$287K	–	12352
2023 Q4	$287K	Hold	12,229	–	–	﹤0.01%	9929
2023 Q3	$291K	Hold	12,229	–	–	﹤0.01%	9410
2023 Q2	$352K	Buy	12,229 +11,618	+1,901%	+$60.2K	﹤0.01%	9115
2023 Q1	$36.8K	Sell	611 -151	-20%	-$1.91K	﹤0.01%	11829
2022 Q4	$70.4K	Buy	762 +16	+2%	+$189	﹤0.01%	11214
2022 Q3	$90K	Buy	746 +14	+2%	+$241	﹤0.01%	11782
2022 Q2	$56K	Buy	732 +146	+25%	+$2.09K	﹤0.01%	11916
2022 Q1	$91K	Sell	586 -26	-4%	-$626	﹤0.01%	11974
2021 Q4	$147K	Sell	612 -141	-19%	-$6.66K	﹤0.01%	11811
2021 Q3	$324K	Buy	753 +303	+67%	+$19.8K	﹤0.01%	10424
2021 Q2	$246K	Buy	+450	New	+$28.2K	﹤0.01%	11174

Other funds holding KRSA

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna International Group's KRSA Position: Q2 2023 in Review

Susquehanna International Group sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2023, closing a stake of 323 shares — an estimated $11.7K sold.

Susquehanna International Group first reported a position in KRSA in Q2 2019 and held it in 14 quarters. The position peaked at $313K in Q2 2021. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

Susquehanna International Group reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 323 Korsana Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $11.7K.
Susquehanna International Group first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
Susquehanna International Group's Korsana Biosciences, Inc. Common Stock position peaked at $313K in Q2 2021.
17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.